About irlabs

This author has not yet filled in any details.
So far irlabs has created 7 blog entries.

Adastra Holdings Reports FY2022 Results; Demonstrating A Second Year of Record Revenue

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Holdings Reports FY2022 Results; Demonstrating A Second Year of Record Revenue2023-05-02T11:42:57+00:00

Adastra Accelerates Growth; 152% Increase in Shipment Volume

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Accelerates Growth; 152% Increase in Shipment Volume2023-03-16T11:31:15+00:00

Adastra to Defend Lawsuit

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra to Defend Lawsuit2023-03-15T20:38:27+00:00

Adastra Labs Clarifies and Retracts Certain Disclosure Related to its Receipt of Health Canada Approval for the Amendment to Include Cocaine Under its Controlled Substances Licence

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Labs Clarifies and Retracts Certain Disclosure Related to its Receipt of Health Canada Approval for the Amendment to Include Cocaine Under its Controlled Substances Licence2023-03-03T22:03:06+00:00

Adastra Labs Receives Health Canada Approval for the Amendment to Include Cocaine Under its Controlled Substances Dealer’s License

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Labs Receives Health Canada Approval for the Amendment to Include Cocaine Under its Controlled Substances Dealer’s License2023-02-22T21:21:09+00:00

Leadership Update: Adastra Appoints Lachlan McLeod as CFO

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Leadership Update: Adastra Appoints Lachlan McLeod as CFO2023-02-14T12:32:34+00:00

Adastra Completes Transaction to Terminate Legacy Supply Agreement, Bringing Phyto Extractions Brand 100% In-House

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Completes Transaction to Terminate Legacy Supply Agreement, Bringing Phyto Extractions Brand 100% In-House2023-02-09T12:37:44+00:00
Go to Top